Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

As former President, CEO and Chairman of a large public company and a seasoned director, Mr. Friel brings extensive experience in global technology companies as well as deep strategic, financial, tax and board leadership experience. He also brings to our Board expertise in leadership development, risk management, corporate governance, including executive compensation, as well as experience leading and integrating strategic transactions.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Director

Xylem Inc. (NYSE: XYL)

Jan 1, 2012 – Present

Independence: Independent

Source effective: 2026-03-30 · Observed: 2026-05-03T01:22:01.992+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Xylem Inc.

2012-01-01 · current

Confirmed by public sourceView source

Director

West Pharmaceutical Services

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

West Pharmaceutical Services

Open West Pharmaceutical Services profile →

Director at West Pharmaceutical Services

Start not stated → End not stated

current · source reported

Observed: 2026-09-21

West Pharmaceutica…West Pharmaceutical ServicesXylem Inc.Xylem Inc.Robert F. Friel

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingXYL DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 2 · Sec FilingWest Pharmaceutical Services, Inc. director board sourceSupports Board membership, Committee assignments, Board independence.Open sourceSource 3 · Sec FilingXylem Inc. director board sourceSupports Board membership, Director since, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:robert-f-friel
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 17, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 17, 2026

Board independence · CorroboratedIndependent directorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of West Pharmaceutical Services, Inc.Supported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Xylem Inc.Supported by 3 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 17, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 17, 2026

Board role · Source reportedBoard role: Lead Independent Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Leadership Development & Compensation1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 17, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 17, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 17, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 17, 2026

Technology background · Source reportedTechnology background reported in filings1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 17, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 17, 2026

View all sources8 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 17, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  2. https://www.sec.gov/Archives/edgar/data/1524472/000110465926036678/xyl-20260514xdef14a.htm

    Sec Proxy · Tier not stated · Reviewed May 3, 2026

    Supports: Director at Xylem Inc. (NYSE: XYL)

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Board independence

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  5. https://www.sec.gov/Archives/edgar/data/105770/000110465926026778/wst-20260504xdef14a.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at West Pharmaceutical Services (NYSE: WST)

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Director since · Board independence

  7. https://www.sec.gov/Archives/edgar/data/1524472/000110465926036678/xyl-20260514xdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  8. https://www.sec.gov/Archives/edgar/data/105770/000110465926026778/wst-20260504xdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership